113 related articles for article (PubMed ID: 9035014)
1. Low dose etodolac in rheumatoid arthritis: a review of early studies.
Spencer-Green G
J Rheumatol Suppl; 1997 Feb; 47():3-9; discussion 48-50. PubMed ID: 9035014
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
Lightfoot R
J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
[TBL] [Abstract][Full Text] [Related]
3. Etodolac, aspirin, and placebo in patients with rheumatoid arthritis: a 12-week study.
Edwards W
Clin Ther; 1983; 5(5):495-503. PubMed ID: 6225520
[TBL] [Abstract][Full Text] [Related]
4. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
Williams GW; Kivitz AJ; Brown MT; Verburg KM
Clin Ther; 2006 Feb; 28(2):204-21. PubMed ID: 16678642
[TBL] [Abstract][Full Text] [Related]
5. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.
Dick WC; Franchimont P; Veys E
Clin Ther; 1993; 15(1):148-59. PubMed ID: 8458044
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of etodolac and placebo in rheumatoid arthritic patients.
Vetter G; Placchi M; Joubert L
Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):240-5. PubMed ID: 6212555
[TBL] [Abstract][Full Text] [Related]
7. Twelve-week study of etodolac, aspirin, and placebo in patients with rheumatoid arthritis.
del Toro RA; ConcepciĆ³n R
Clin Ther; 1983; 5(4):436-44. PubMed ID: 6223699
[TBL] [Abstract][Full Text] [Related]
8. Double blind evaluation of the long-term effects of etodolac versus ibuprofen in patients with rheumatoid arthritis.
Neustadt DH
J Rheumatol Suppl; 1997 Feb; 47():17-22. PubMed ID: 9035016
[TBL] [Abstract][Full Text] [Related]
9. Clinical performance of etodolac in patients with osteoarthritis and rheumatoid arthritis.
Veys EM
Eur J Rheumatol Inflamm; 1994; 14(1):23-7. PubMed ID: 7744125
[TBL] [Abstract][Full Text] [Related]
10. Etodolac versus diclofenac: double-blind cross-over study in rheumatoid arthritis.
Ciompi ML; Puccetti L; Bazzichi L; Remorini E; Marotta G
Int J Clin Pharmacol Res; 1989; 9(3):217-22. PubMed ID: 2526101
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
[TBL] [Abstract][Full Text] [Related]
12. An overview of the efficacy of etodolac in arthritic disorders.
Bacon PA
Eur J Rheumatol Inflamm; 1990; 10(1):22-34. PubMed ID: 2146130
[TBL] [Abstract][Full Text] [Related]
13. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.
Yocum DE; Furst DE; Bensen WG; Burch FX; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisememandle W; Mekki QA;
Rheumatology (Oxford); 2004 Aug; 43(8):992-9. PubMed ID: 15014199
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA
Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503
[TBL] [Abstract][Full Text] [Related]
15. Etodolac, aspirin, and placebo in patients with degenerative joint disease: a twelve-week study.
Andelman SY
Clin Ther; 1983; 5(6):651-61. PubMed ID: 6226358
[TBL] [Abstract][Full Text] [Related]
16. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, parallel-group evaluation of etodolac and naproxen in patients with acute sports injuries.
D'Hooghe M
Clin Ther; 1992; 14(4):507-16. PubMed ID: 1388091
[TBL] [Abstract][Full Text] [Related]
18. Double-blind comparison of etodolac and naproxen in the treatment of rheumatoid arthritis.
de Queiros MF
Clin Ther; 1991; 13(1):38-46. PubMed ID: 1827613
[TBL] [Abstract][Full Text] [Related]
19. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
Kalden JR; Scott DL; Smolen JS; Schattenkirchner M; Rozman B; Williams BD; Kvien TK; Jones P; Williams RB; Oed C; Rosenburg R;
J Rheumatol; 2001 Sep; 28(9):1983-91. PubMed ID: 11550964
[TBL] [Abstract][Full Text] [Related]
20. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study.
Bachert C; Chuchalin AG; Eisebitt R; Netayzhenko VZ; Voelker M
Clin Ther; 2005 Jul; 27(7):993-1003. PubMed ID: 16154478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]